Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania 19129, USA.
J Neurochem. 2010 Jul;114(1):62-73. doi: 10.1111/j.1471-4159.2010.06720.x. Epub 2010 Mar 31.
Understanding the interaction between dopamine and glutamate, particularly the interaction of dopamine and NMDA receptors, may enable a more rational approach to the treatment of schizophrenia, drug addiction, and other psychiatric disorders. We show that, in prefrontal cortical neurons, dopamine D(1)-induced enhancement of NMDA receptor function depends on rapid insertion of new NMDA receptor 2B subunits on the synaptic surface. Protein kinase A (PKA) inhibitor, but not protein kinase C (PKC) inhibitor, completely blocked dopamine D(1) agonist SKF-81297-induced increase of the total expression of NMDA receptors. Furthermore, SKF-81297 failed to alter the surface expression and synaptic insertion of NMDA receptors in the presence of PKA inhibitor, phospholipase C inhibitor, PKC inhibitor, or Src family kinase inhibitor. Our data suggest that D(1)-mediated enhancement of NMDA current depends on the NMDA receptor trafficking through rapid synaptic insertion and both PKA and PKC signaling pathways play important roles in the regulatory process. Although both PKA and PKC mediate the D(1)-induced enhancement of NMDA receptors, the phospholipase C-PKC-Src pathway is only required for surface expression and new synaptic insertion of NMDA receptors.
了解多巴胺和谷氨酸之间的相互作用,特别是多巴胺和 NMDA 受体之间的相互作用,可能使我们能够更合理地治疗精神分裂症、药物成瘾和其他精神疾病。我们发现,在额皮质神经元中,多巴胺 D1 诱导的 NMDA 受体功能增强依赖于新的 NMDA 受体 2B 亚基在突触表面的快速插入。蛋白激酶 A(PKA)抑制剂,但不是蛋白激酶 C(PKC)抑制剂,完全阻断了多巴胺 D1 激动剂 SKF-81297 诱导的 NMDA 受体总表达的增加。此外,在 PKA 抑制剂、磷脂酶 C 抑制剂、PKC 抑制剂或 Src 家族激酶抑制剂存在的情况下,SKF-81297 未能改变 NMDA 受体的表面表达和突触插入。我们的数据表明,D1 介导的 NMDA 电流增强依赖于 NMDA 受体通过快速突触插入的转运,PKA 和 PKC 信号通路都在调节过程中发挥重要作用。虽然 PKA 和 PKC 都介导了 D1 诱导的 NMDA 受体增强,但磷脂酶 C-PKC-Src 途径仅需要 NMDA 受体的表面表达和新的突触插入。